Augmedix, Inc.
AUGX · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.4% | 6.2% | 7.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 47.2% | 47.1% | 49.3% | 49.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -53.5% | -41% | -28.1% | -27.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -61.8% | -48.2% | -35.4% | -37.5% |
| EPS Diluted | -0.16 | -0.12 | -0.092 | -0.097 |
| % Growth | -33.3% | -31% | 5.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |